Job Description

Preparation of Monthly P&L account analysis and Balance sheet account analysis for critical accounts as identified and mentioned in the Standard Operating Procedures Reply to Site finance queries on the clarifications and further analysis on items called for Deliver cash flow forecasts and compare actuals vs forecasts on a weekly basis Work with other GBSS internal teams to ensure that processes like Bank Reconciliations, Sub ledger reconciliations are delivered as per the Standard operating procedures Work with Site finance teams on preparation of Local Gaap Financial statements Manage the audit deliverables Both Internal and external for various which are in Scope Continually assess opportunities to improve the efficiency and effectiveness of the process with automation as the key driver of performing repetitive tasks Setup governance mechanism(frequency) and the metrics to be reported in consultation with site controllers Proactively identify opportunities which can be transitioned to shared services and setup the execution plan Motivate team members and help them in critical steps and assign stretch goals for enhancing performance Build and maintain strong relationships with business units/sites. Oversee the processing team's communications and interactions with business units/sites to ensure effective and appropriate communication occurs as required. Ensure that systems and procedures are in compliance with company policies and applicable regulations. Consistently review balance sheet accounts in SAP to ensure completeness and maintain cleanliness of the GL accounts by adopting best practices of SAP Ensure that the Standard operating procedures is upto date and all the process changes are updated immediately and signed off by the relevant stakeholders

In the three decades of its existence, Piramal Group has pursued a twin strategy of both organic and inorganic growth.
Driven by its core values, Piramal Group steadfastly pursues inclusive growth, while adhering to ethical and values-driven practices.

Equal employment opportunity

Piramal Group is proud to be an Equal Employment Opportunity and Affirmative Action employer. We do not discriminate based upon race, ethnicity, religion, color, national origin, gender (including pregnancy, childbirth, or related medical conditions), sexual orientation, gender identity, gender expression, age, status as a protected veteran, status as an individual with a disability, genetics, or other applicable legally protected characteristics.



We base our employment decisions on merit considering qualifications, skills, performance, and achievements. We endeavor to ensure that all applicants and employees receive equal opportunity in personnel matters, including recruitment, selection, training, placement, promotion, demotion, compensation and benefits, transfers, terminations, and working conditions, including reasonable accommodation for qualified individuals with disabilities as well as individuals with needs related to their religious observance or practice.

Piramal Pharma Limited (PPL) offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 15 global facilities and a global distribution network in over 100 countries. PPL includes Piramal Pharma Solutions (PPS), an integrated Contract Development and Manufacturing Organization; Piramal Critical Care (PCC), a Complex Hospital Generics business, and the India Consumer Healthcare business selling over-the-counter products.


PPS offers end-to-end development and manufacturing solutions through a globally integrated network of facilities across the drug life cycle to innovators and generic companies. PCC's complex hospital product portfolio includes inhalation anaesthetics, intrathecal therapies for spasticity and pain management, injectable pain and anaesthetics, injectable anti-infectives, and other therapies. The Indian Consumer Healthcare business is among the leading players in India in the self-care space, with established brands in the Indian consumer healthcare market. In addition, PPL has a joint venture with Allergan, a leader in ophthalmology in the Indian formulations market. In October 2020, the company received a growth equity investment from the Carlyle Group.